[儿科患者中与神经纤维化1相关的瘤]
V S Deryugina1, Y K Toshina1, I L Nikitina1
1Almazov National Medical Research Center.
概括
1型神经纤维素瘤病 (NF1) 管理需要多学科的护理,以早期检测瘤. 这一案例突显了青少年形神经纤维瘤和染细胞瘤的成功治疗,改善了他们的生活质量.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 儿科 儿科 儿科
背景情况:
- 神经纤维素瘤类型1 (NF1) 是一种遗传性疾病,具有终身瘤风险.
- 早期检测和监测对于管理NF1并发症至关重要.
- 在NF1的瘤可以导致显著的残疾和减少预期寿命.
研究的目的:
- 提出一个临床案例,一个青春期女性患有症状NF1相关的瘤.
- 强调在管理NF1时采用多学科方法的重要性.
- 为了说明针对性治疗和综合护理的有利结果.
主要方法:
- 一个患有NF1.1的青少年女性患者的病例报告.
- Plexiform 神经纤维瘤和花色细胞瘤的诊断和治疗.
- 涉及专家的多学科团队方法.
- 实施查计划和有针对性的治疗.
主要成果:
- 这位患者出现了症状的plexiform神经纤维瘤和 pheochromocytoma.
- 多学科的方法和适当的治疗导致了有利的结果.
- 患者的生活质量得到改善,允许恢复正常的生活方式.
- 针对性治疗在治疗后继续进行.
结论:
- 综合监测和多学科方法对于管理NF1.1至关重要.
- 早期和正确治疗NF1相关瘤可以带来积极的患者结果.
- 有效的管理可以显著改善NF1.1患者的生活质量.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism
236
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
SN1 Reaction: Stereochemistry
10.4K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.4K
SN1 Reaction: Kinetics
9.6K
In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.6K


